Strategy for Designing a Synthetic Tumor Vaccine: Multi-Component, Multivalency and Antigen Modification

Synthetic tumor vaccines have been proven to be promising for cancer immunotherapy. However, the limitation of the specificity and efficiency of the synthetic tumor vaccines need further improvements. To overcome these difficulties, additional tumor-associated targets need to be identified, and opti...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Zhi-Hua, Sun, Zhan-Yi, Gao, Yue, Chen, Pu-Guang, Liu, Yan-Fang, Chen, Yong-Xiang, Li, Yan-Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494217/
https://www.ncbi.nlm.nih.gov/pubmed/26344745
http://dx.doi.org/10.3390/vaccines2030549

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494217/
https://www.ncbi.nlm.nih.gov/pubmed/26344745
http://dx.doi.org/10.3390/vaccines2030549

Ejemplares similares